Removing Testosterone from the Prescription Drug Monitoring Program (S 2889, H 8318)

We supported legislation which would exempt testosterone prescriptions from being transmitted or reported within the Department of Health's prescription drug monitoring database (PDMP) and would remove from the database all existing information concerning prior testosterone prescriptions. This database was originally established to address the misuse of controlled substances by tracking prescriptions issued under specific provisions of the Uniform Controlled Substances Act. However, this requirement fails to account for testosterone as gender-affirming care. This legislation is necessary given the current presidential administration's continued attacks on transgender individuals. This legislation passed the Senate, but died in the House Health and Human Services committee.